Infection Control for the Human Animal Health Market

The increasing prevalence of infectious diseases serves as a significant driver for Infection Control for the Human and Animal Health Market. In recent years, there has been a notable surge in the prevalence of various infectious diseases worldwide, contributing to an increased demand for infection control products and measures. According to the World Health Organization (WHO), infectious diseases remain a leading cause of global morbidity and mortality, affecting millions of people annually. For instance, the COVID-19 pandemic, caused by the novel coronavirus (SARS-CoV-2), has underscored the importance of effective infection control strategies.

As of January 21, 2024, latest available statistics by Worldometer, the total number of confirmed COVID-19 cases globally is approximately 702,115,249. Moreover, other infectious diseases such as influenza, bacterial infections, parasitic diseases, and fungal infections continue to pose significant public health challenges. According to the WHO, in 2022, there were approximately 249 million malaria cases and 608,000 malaria deaths in 85 countries.

The rising awareness of infection control measures represents a pivotal driver for Infection Control for the Human and Animal Health Market. Heightened public and professional awareness about the importance of infection prevention has been fostered by the experiences of recent pandemics and global health crises. Increased media coverage, educational campaigns, and government initiatives have contributed to a more informed populace and healthcare community. Individuals and healthcare professionals alike are recognizing the critical role of disinfection products, personal protective equipment (PPE), and sterilization equipment in curbing the spread of infectious diseases.

With a growing emphasis on infection control protocols in various settings, including hospitals, clinics, and public spaces, there is a corresponding surge in the demand for advanced and effective infection control solutions.  

The increasing number of infectious diseases is driving a higher demand worldwide for infection control in both human and animal health sectors. This is primarily due to increased awareness and the urgent need for effective measures in addressing pandemics and ongoing public health issues.

The increasing awareness of health and hygiene among populations worldwide appears to be a significant driver for the Global Infection Control for the Human and Animal Health Market Industry. As individuals become more informed about the risks associated with infections, there is a growing demand for effective infection control measures. This trend is particularly evident in developing regions where public health campaigns emphasize the importance of sanitation and hygiene. Consequently, the market is projected to reach 10.3 USD Billion in 2024, reflecting the heightened focus on preventing infections in both human and animal health sectors.

The establishment of stringent regulatory frameworks and standards for infection control practices is a crucial driver for the Global Infection Control for the Human and Animal Health Market Industry. Governments and health organizations are increasingly implementing guidelines that mandate the use of effective infection control measures in healthcare settings and veterinary practices. This regulatory support not only enhances compliance but also fosters innovation in the development of new products. As a result, the market is likely to experience a compound annual growth rate of 8.16% from 2025 to 2035, reflecting the ongoing commitment to improving health outcomes.

The increasing expenditure on veterinary care is a notable driver for the Global Infection Control for the Human and Animal Health Market Industry. Pet ownership and livestock farming are on the rise, leading to higher demand for veterinary services and products aimed at infection control. As pet owners and farmers prioritize the health of their animals, investments in preventive care and infection management are becoming more common. This trend is likely to contribute to the overall market growth, as the focus on animal health parallels advancements in human health, creating a synergistic effect in infection control practices.

The rising incidence of infectious diseases globally is a pressing concern that drives the Global Infection Control for the Human and Animal Health Market Industry. Factors such as urbanization, climate change, and increased travel contribute to the spread of pathogens, necessitating robust infection control measures. For example, outbreaks of zoonotic diseases highlight the interconnectedness of human and animal health, prompting a unified approach to infection prevention. This growing urgency for effective solutions is expected to bolster market growth, as stakeholders seek to mitigate the impact of infectious diseases on public health.

Technological innovations in infection control products and practices are likely to propel the Global Infection Control for the Human and Animal Health Market Industry. Advancements in sterilization techniques, antimicrobial coatings, and rapid diagnostic tools contribute to more effective infection management. For instance, the introduction of automated disinfection systems in healthcare facilities has shown promising results in reducing infection rates. As these technologies become more accessible, the market is expected to grow significantly, potentially reaching 24.5 USD Billion by 2035, driven by the need for enhanced safety and efficacy in infection control.

By region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World.

North America accounted for the largest market share of over 33.75% in 2022, owing to the increasing advanced healthcare infrastructure, stringent regulations, and high awareness regarding infection control measures and the rising number of surgical procedures in the region. PPE is frequently utilized in orthopedic surgery in order to prevent infections in patients and healthcare providers too. According to the American Joint Replacement Registry's 2021 annual report, there were 2,244,587 hip and knee procedures performed.

Further, the major countries studied are: The US, Canada, Brazil, Germany, France, the UK, Italy, Spain, China, India, Japan, South Korea, and Australia.

FIGURE 3: Infection Control For The Human And Animal Health Market, By Region, 2022 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe infection control for the human and animal health market shows significant growth during the forecast year, i.e., 2022–2023, owing to the increasing infections cases across the Europe. The infection control market in Europe, encompassing both human and animal health, is witnessing a robust surge driven by the increasing awareness of infectious diseases and the need for advanced preventive measures.

According to the World Health Organisation on June 26, 2023, Croatia, Italy, Spain, Sweden, and the United Kingdom of Great Britain and Northern Ireland have reported an increase in confirmed cases of E-11 infection in neonates and infants, with high morbidity and mortality. Furthermore, E-11 can be transmitted vertically from mother to child, complicating infection control efforts. The infections can cause severe inflammatory illnesses in neonates, such as severe acute hepatitis with coagulopathy. E-11 and other enteroviruses have been circulating continuously in Europe.

Furthermore, the Germany infection control for the human and animal health market held the largest market share in 2022 and France infection control for the human and animal health market is the fastest growing market in the Europe region.

The Asia-Pacific region is a dynamic and diverse market for infection control in both human and animal health. With a rapidly growing population, increased urbanization, and rising awareness about healthcare standards, the demand for effective infection prevention and control measures is on the rise. According to the United Nations Population Fund (UNFPA), Asia and the Pacific account for 60% of the world's population, or approximately 4.3 billion people.

Furthermore, an increasing in population density not only affects the spread of infectious diseases directly (for example, through increased human-to-human contact), but it also underpins many other ecological driving forces such as changing land use, agriculture, and livestock intensification. Moreover, China infection control for the human and animal health market held the largest market share in 2022 and India infection control for the human and animal health market is the fastest growing market in the Asia-Pacific region.

The Infection Control for the Human and Animal Health Market is characterized by the presence of many global, regional, and local players and factors such as lowering the cost of the products, improving infrastructure and increasing adoption of infection control products are driving the growth of the Infection Control for the Human and Animal Health Market. To expand their reach and optimize their operational costs, the major players focus on forming strategic and in order to gain a substantial market share.

Advanced Sterilization Products (US) is a leader in infection prevention, dedicated to developing the products, solutions, and processes that practitioners require to protect patients. It offers products through categories such as terminal sterilization, sterilization monitoring, high-level disinfection, and connectivity. Its terminal sterilization (TS) solutions to assist in the quick and compliant reprocessing of surgical instruments. It has more than 1,700 employees across 100 countries. It has presence across region’s namely Americas, Europe, Asia-Pacific, Middle East & Africa.

Moreover, in April 2019, the company launched AEROFLEX Automatic Endoscope Reprocessor (AER), a single basin system automates the washing and high-level disinfection cycle of flexible semi-critical endoscopes. This launch has helped the company expand its reach in developing regions and generate sales.